These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1230039)

  • 1. [Serological response in man to an anticholera vaccine made from killed vibrios and partially purified with aluminium hydroxide].
    Soscia M; Saletti M; Ricci A; Di Gioia M
    Ann Sclavo; 1975; 17(3):257-66. PubMed ID: 1230039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and laboratory testing of plain and aluminum hydroxide-adsorbed cholera vaccines used in a field trial in Indonesia.
    Joó I; Csizér Z
    Bull World Health Organ; 1978; 56(4):615-8. PubMed ID: 310362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serologic response in man to cholera vaccine].
    Di Tommaso I
    Ann Sclavo; 1973; 15(4):445-52. PubMed ID: 4788453
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of Vibrio antibody titers during anti-cholera vaccination].
    Dirimci OT; Cinar V
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
    [No Abstract]   [Full Text] [Related]  

  • 13. Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.
    Cash RA; Music SI; Libonati JP; Schwartz AR; Hornick RB
    Infect Immun; 1974 Oct; 10(4):762-4. PubMed ID: 4426706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae.
    Mosley WH; McCormack WM; Ahmed A; Chowdhury AK; Barui RK
    Bull World Health Organ; 1969; 40(2):187-97. PubMed ID: 5306539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A one dose experimental cholera vaccine.
    Muse M; Grandjean C; Wade TK; Wade WF
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
    Levine MM; Kaper JB; Herrington D; Losonsky G; Tacket C; Tall B
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):401-15. PubMed ID: 3217822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity testing of plain and aluminium hydroxide-adsorbed whole-cell cholera vaccines.
    Joó I
    Acta Trop; 1979 Jun; 36(2):151-6. PubMed ID: 41423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the efficacy of cholera vaccination in a population sample of Bari].
    Barbuti S; Iandolo E; Leogrande G; Rizzo G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):489-99. PubMed ID: 1230049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
    Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.